Y. Lim

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Yoon-pin Lim, Yoongho Lim, Yoon‐pin Lim, Yoon Pin Lim
Publication record
68 papers · 2,582 citations · H-index 30

PAPERS

Genomic, transcriptomic, and metabolomic analysis of Oldenlandia corymbosa reveals the biosynthesis and mode of action of anti-cancer metabolites.
202317 citationsauthor #9
Impairment of Glucose Metabolism and Suppression of Stemness in MCF-7/SC Human Breast Cancer Stem Cells by Nootkatone
202213 citationsauthor #6
Bioorthogonal Catalysis for Treatment of Solid Tumors Using Thermostable, Self-Assembling, Single Enzyme Nanoparticles and Natural Product Conversion with Indole-3-acetic Acid
202215 citationsauthor #8
Genomic, transcriptomic, and metabolomic analysis of Traditional Chinese Medicine plant Oldenlandia corymbosa reveals the biosynthesis and mode of action of anti-cancer metabolites
20221 citationsauthor #9
Reciprocal Regulation of Hippo and WBP2 Signalling—Implications in Cancer Therapy
20216 citationsauthor #4
WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway
202113 citationsauthor #6
WBP2 inhibits microRNA biogenesis via interaction with the microprocessor complex
20216 citationsauthor #5
WBP2 promotes BTRC mRNA stability to drive migration and invasion in triple‐negative breast cancer via NF‐κB activation
202124 citationsauthor #4
The emerging roles of WBP2 oncogene in human cancers
202028 citationsauthor #6
Hippo/MST blocks breast cancer by downregulating WBP2 oncogene expression via miRNA processor Dicer
202017 citationsauthor #9
Signal Transduction of a Novel WBP2 Oncogene
20200 citationsauthor #3
The transcriptional coactivator WBP2 primes triple-negative breast cancer cells for responses to Wnt signaling via the JNK/Jun kinase pathway
201827 citationsauthor #4
Elevated WBP2 Expression in HER2-positive Breast Cancers Correlates with Sensitivity to Trastuzumab-based Neoadjuvant Therapy: A Retrospective and Multicentric Study
201815 citationsauthor #15
Linc‐9432 is a novel pterygium lincRNA which regulates differentiation of fibroblasts
20189 citationsauthor #4
TRPV4 plays a role in breast cancer cell migration via Ca2+-dependent activation of AKT and downregulation of E-cadherin cell cortex protein
2017107 citationsauthor #10
TRPV4 plays a role in breast cancer cell migration via Ca2+-dependent activation of AKT and downregulation of E-cadherin cell cortex protein
2017107 citationsauthor #11
Plasma LRG1 Protein Are Overexpressed in Acute Myeloid Leukemia with High Sensitivity and High Specificity in Differentiating Leukemic Plasma from Normal Plasma — a Potential Biomarker for Minimal Residual Disease Detection
20170 citationsauthor #7
RNAi Reveals Phase-Specific Global Regulators of Human Somatic Cell Reprogramming.
201647 citationsauthor #18
Comparative Proteomic Profiling of Extracellular Proteins between Normal and Gastric Cancer Cells.
20165 citationsauthor #5
S100P is Overexpressed in Squamous Cell and Adenosquamous Carcinoma Subtypes of Endometrial Cancer and Promotes Cancer Cell Proliferation and Invasion
201613 citationsauthor #4
Wnt Signaling Promotes Breast Cancer by Blocking ITCH-Mediated Degradation of YAP/TAZ Transcriptional Coactivator WBP2.
201677 citationsauthor #19
In vitro secretomics study of pterygium-derived fibroblasts by iTRAQ-based quantitative proteomics strategy.
201612 citationsauthor #4
Proteomic profiling predicts drug response to novel targeted anticancer therapeutics
201610 citationsauthor #4
TRPV4 Regulates Breast Cancer Cell Extravasation, Stiffness and Actin Cortex
2016119 citationsauthor #16
DLAT subunit of the pyruvate dehydrogenase complex is upregulated in gastric cancer-implications in cancer therapy.
201588 citationsauthor #5
Original Article DLAT subunit of the pyruvate dehydrogenase complex is upregulated in gastric cancer-implications in cancer therapy
20150 citationsauthor #6
Secretomics in pterygium-derived fibroblasts: discovery of pathological molecules in disease
20150 citationsauthor #4
Cep68 can be regulated by Nek2 and SCF complex.
201524 citationsauthor #3
Evaluation of Global Differential Gene and Protein Expression in Primary Pterygium: S100A8 and S100A9 as Possible Drivers of a Signaling Network
201427 citationsauthor #6
EZH2-mediated inactivation of IFN-γ-JAK-STAT1 signaling is an effective therapeutic target in MYC-driven prostate cancer.
2014100 citationsauthor #5
Human Finger‐Prick Induced Pluripotent Stem Cells Facilitate the Development of Stem Cell Banking
201450 citationsauthor #13
CXCL3 is a potential target for breast cancer metastasis.
201457 citationsauthor #4
Divide and conquer: subproteomic approaches toward gastric cancer biomarker and drug target discovery
20146 citationsauthor #4
The use of transformed IMR90 cell model to identify the potential extra-telomeric effects of hTERT in cell migration and DNA damage response
20145 citationsauthor #4
DEAD-box helicase DP103 defines metastatic potential of human breast cancers.
2014117 citationsauthor #18
Recent advances in mass spectrometry: data independent analysis and hyper reaction monitoring
2013134 citationsauthor #2
Discovery of SLC3A2 cell membrane protein as a potential gastric cancer biomarker: implications in molecular imaging.
201259 citationsauthor #8
EGFR S1166 phosphorylation induced by a combination of EGF and gefitinib has a potentially negative impact on lung cancer cell growth.
201219 citationsauthor #6
Structure of a novel phosphotyrosine‐binding domain in Hakai that targets E‐cadherin
201273 citationsauthor #15
Elevated NRD1 metalloprotease expression plays a role in breast cancer growth and proliferation
201117 citationsauthor #9
Tyrosine phosphorylation of transcriptional coactivator WW‐domain binding protein 2 regulates estrogen receptor α function in breast cancer via the Wnt pathway
201155 citationsauthor #5
Hemoglobin subunit beta (HBB) is a potential biomarker for predicting response to Gefitinib in NSCLC patients
20110 citationsauthor #7
Biological models of breast cancer: one size does not fit all
20111 citationsauthor #2
Upregulation of plasma C9 protein in gastric cancer patients
201065 citationsauthor #14
Cathepsin S mediates gastric cancer cell migration and invasion via a putative network of metastasis-associated proteins.
201089 citationsauthor #11
EGF-induced tyrosine phosphorylation of Endofin is dependent on PI3K activity and proper localization to endosomes.
20109 citationsauthor #4
Proteome-Wide Profiling of the MCF10AT Breast Cancer Progression Model
201046 citationsauthor #6
Abstract 4971: WBP2: A novel phospho-oncoprotein in estrogen receptor-positive breast cancer
20100 citationsauthor #4
ITIH3 is a potential biomarker for early detection of gastric cancer.
201066 citationsauthor #13
Reduced plasma APOA1 level is associated with gastric tumor growth in MKN45 mouse xenograft model.
201051 citationsauthor #9
Regulation of macrophage inhibitory factor (MIF) by epidermal growth factor receptor (EGFR) in the MCF10AT model of breast cancer progression.
200915 citationsauthor #5
Novel breast cancer metastasis-associated proteins.
2009126 citationsauthor #10
Phosphoproteomics, oncogenic signaling and cancer research
200836 citationsauthor #6
Progressive loss of EGFR in a subpopulation of breast cancers: Implications in target-directed therapeutics
20071 citationsauthor #16
Development of automated laser capture microdissection for cancer biomarker discovery
20070 citationsauthor #7
A preliminary study on gastric cancer plasma in Singapore
20070 citationsauthor #7
Phosphoproteomics identified Endofin, DCBLD2, and KIAA0582 as novel tyrosine phosphorylation targets of EGF signaling and Iressa in human cancer cells
200749 citationsauthor #15
Endofin is a novel component in EGF/EGFR oncogenic signaling
20070 citationsauthor #2
Progressive loss of epidermal growth factor receptor in a subpopulation of breast cancers: implications in target-directed therapeutics
200732 citationsauthor #16
Differential Expression of Novel Tyrosine Kinase Substrates during Breast Cancer Development *S
2007133 citationsauthor #13
Novel tyrosine phosphorylation targets of EGF signaling and gefitinib in human cancer cells.
20071 citationsauthor #15
Mining the Tumor Phosphoproteome for Cancer Markers
200589 citationsauthor #1
Selective Tyrosine Hyperphosphorylation of Cytoskeletal and Stress Proteins in Primary Human Breast Cancers
200440 citationsauthor #1
Phosphoproteomic fingerprinting of epidermal growth factor signaling and anticancer drug action in human tumor cells.
200351 citationsauthor #1
Tyrosine Phosphorylation of the Bcl-2-associated Protein BNIP-2 by Fibroblast Growth Factor Receptor-1 Prevents Its Binding to Cdc42GAP and Cdc42*
199948 citationsauthor #2
Association of Atypical Protein Kinase C Isotypes with the Docker Protein FRS2 in Fibroblast Growth Factor Signaling*
199939 citationsauthor #1
Growth Factors Stimulate Tyrosine Dephosphorylation of p75 and Its Dissociation from the SH2 Domain of Grb2*
19976 citationsauthor #1
Identification of p90, a Prominent Tyrosine-phosphorylated Protein in Fibroblast Growth Factor-stimulated Cells, as 80K-H (*)
199672 citationsauthor #2

TIMELINE

1996 72 citations

1997 6 citations

1999 87 citations

2003 51 citations

2004 40 citations

2005 89 citations

2007 216 citations

2008 36 citations

2009 141 citations

2010 326 citations

2011 73 citations

2012 151 citations

2013 134 citations

2014 362 citations

2015 112 citations

2016 283 citations

2017 107 citations

2018 51 citations

2020 45 citations

2021 49 citations

2022 29 citations

2023 17 citations

COAUTHOR MAP

CONCEPT FOOTPRINT